300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Andorra
Guernsey
Cameroon
Sudan
Colombia
Armenia
China
Czech Republic
Costa Rica
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Ireland
Malaysia
Philippines
Portugal
Mali
Rwanda
Sierra Leone
Senegal
Tanzania
El Salvador
India
Indonesia
Germany
United States
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Ecuador
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Life Science Startup Investors (September 2026)

The most active venture capital funds and angel investors investing in Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Life Science startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
SOSV
VC Fund
51 United States, India, United Kingdom Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software
ARCH Venture Partners
VC Fund
43 United States, China, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $9.5M–$230M
Alexandria Venture Investments
VC Fund
39 United States, Canada, France Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2M–$150M
Alumni Ventures
VC Fund
36 United States, United Kingdom, Canada Seed, Series A, Series B Software, Artificial Intelligence, Information Technology $880k–$75M
Google Ventures
VC Fund
30 United States, United Kingdom, Israel Series A, Series B, Seed Software, Health Care, Biotechnology $1.2M–$121M
Sofinnova Partners
VC Fund
29 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $7M–$105M
OrbiMed
VC Fund
28 United States, China, Israel Series B, Series A, Series C Biotechnology, Health Care, Medical $9.8M–$160M
Bpifrance
VC Fund
28 France, United States, Switzerland Seed, Series A Software, Information Technology, Health Care $757k–$34M
8VC
VC Fund
27 United States, United Kingdom, Canada Series A, Seed, Series B Software, Health Care, Artificial Intelligence $2.5M–$175M
Parkwalk Advisors
VC Fund
25 United Kingdom, United States, Philippines Seed, Series A, Series B Biotechnology, Health Care, Software $991k–$45M
Atlas Venture
VC Fund
25 United States, United Kingdom, Canada Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $3.6M–$115M
Gaingels
VC Fund
23 United States, Canada, Mexico Seed, Series A, Series B Software, Health Care, Artificial Intelligence $1M–$100M
Northpond Ventures
VC Fund
23 United States, United Kingdom, Canada Series A, Series B, Series C Biotechnology, Health Care, Life Science $13M–$95M
Third Rock Ventures
VC Fund
22 United States Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $11M–$190M
RA Capital Management
VC Fund
21 United States, United Kingdom, Canada Series B, Series C, Post-IPO Equity Biotechnology, Health Care, Therapeutics $27M–$240M
Novartis Venture Fund
VC Fund
20 United States, Switzerland, United Kingdom Series B, Series A, Series C Biotechnology, Health Care, Therapeutics $5.1M–$120M
Andreessen Horowitz
VC Fund
20 United States, United Kingdom, Brazil Series A, Seed, Series B Software, Information Technology, Artificial Intelligence $1.6M–$112M
Liquid 2 Ventures
VC Fund
20 United States, Mexico, Canada Seed, Series A, Pre-Seed Software, Artificial Intelligence, Information Technology $125k–$45M
Fifty Years
VC Fund
20 United States, Germany, Canada Seed, Series A, Pre-Seed Biotechnology, Health Care, Artificial Intelligence $572k–$37M
Oxford Science Enterprises
VC Fund
19 United Kingdom, United States, Finland Seed, Series A, Series B Health Care, Biotechnology, Software $1.3M–$168M
Antler
VC Fund
19 Singapore, Australia, United Kingdom Pre-Seed, Seed, Series A Software, Artificial Intelligence, Information Technology $100k–$29M
2048 Ventures
VC Fund
18 United States, Canada, United Kingdom Pre-Seed, Seed, Series A Artificial Intelligence, Software, Health Care $615k–$16M
SR One
VC Fund
18 United States, United Kingdom, Canada Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $6M–$175M
M Ventures
VC Fund
17 United States, United Kingdom, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2.4M–$100M
Lux Capital
VC Fund
17 United States, United Kingdom, Canada Series A, Seed, Series B Software, Artificial Intelligence, Health Care $1.8M–$150M
Khosla Ventures
VC Fund
17 United States, India, United Kingdom Series A, Series B, Seed Software, Artificial Intelligence, Health Care $2M–$100M
UK Innovation & Science Seed Fund
VC Fund
17 United Kingdom, United States Seed, Series A Biotechnology, Health Care, Medical $482k–$14M
Felicis
VC Fund
16 United States, Canada, Germany Series A, Seed, Series B Software, Artificial Intelligence, SaaS $1.5M–$75M
Flagship Pioneering
VC Fund
16 United States, Canada, United Kingdom Series B, Series C, Series A Biotechnology, Health Care, Medical $6.5M–$230M
DCVC
VC Fund
16 United States, Canada, United Kingdom Seed, Series A, Series B Software, Artificial Intelligence, Machine Learning $1.2M–$130M
Versant Ventures
VC Fund
16 United States, Switzerland, Canada Series A, Series B, Series C Biotechnology, Health Care, Medical $5M–$108M
KdT Ventures
VC Fund
15 United States, India, Canada Seed, Series A, Series B Biotechnology, Health Care, Medical $2.6M–$175M
Omega Funds
VC Fund
15 United States, Switzerland, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $14M–$208M
General Catalyst
VC Fund
15 United States, United Kingdom, India Series A, Seed, Series B Software, Artificial Intelligence, Health Care $1.8M–$125M
Future Planet Capital
VC Fund
15 United Kingdom, United States, Singapore Seed, Convertible Note Biotechnology, Health Care, Software $670k–$5.1M
Novo Holdings
VC Fund
15 United States, Denmark, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $9.5M–$135M
Catalio Capital Management
VC Fund
15 United States, Switzerland, Israel Series A, Series B Biotechnology, Health Care, Life Science $9.7M–$150M
F-Prime
VC Fund
14 United States, United Kingdom, China Series A, Series B, Series C Health Care, Biotechnology, Medical $9.2M–$150M
Syncona Partners LLP
VC Fund
14 United Kingdom, United States, Switzerland Series A, Series B, Seed Biotechnology, Medical, Health Care $1.9M–$156M
Bossa Invest
VC Fund
14 United States, Brazil, Mexico Seed, Pre-Seed, Venture - Series Unknown Software, Information Technology, Financial Services $50k–$36M
Right Side Capital Management
VC Fund
14 United States, Canada, United Kingdom Seed, Pre-Seed, Convertible Note Software, SaaS, Health Care $50k–$2M
Foresite Capital
VC Fund
14 United States, United Kingdom, China Series B, Series C, Series A Biotechnology, Health Care, Therapeutics $16M–$270M
Apple Tree Partners
VC Fund
14 United States, Canada, United Kingdom Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $3.5M–$100M
Alix Ventures
VC Fund
14 United States Seed, Series A, Pre-Seed Health Care, Biotechnology, Life Science $2M–$70M
Civilization Ventures
VC Fund
13 United States, United Kingdom, Brazil Seed, Series A, Series B Biotechnology, Health Care, Medical $1.8M–$144M
Pear VC
VC Fund
13 United States, Brazil, Colombia Seed, Pre-Seed, Series A Software, Artificial Intelligence, Information Technology $250k–$40M
Cormorant Asset Management
VC Fund
13 United States, China, Switzerland Series B, Series C, Series A Biotechnology, Health Care, Medical $16M–$150M
Jonathan Milner
Angel
13 United Kingdom, United States, Spain Seed, Series A, Series B Biotechnology, Health Care, Medical $537k–$56M
Forbion Capital Partners
VC Fund
13 United States, United Kingdom, The Netherlands Series B, Series A, Series C Biotechnology, Health Care, Medical $16M–$180M
Village Global
VC Fund
13 United States, United Kingdom, India Seed, Pre-Seed, Series A Software, Artificial Intelligence, Financial Services $250k–$22M
Access all 7362 investors in Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

SOSV
VC Fund · Princeton, New Jersey, United States · 51 investments in Life Science startups, 70 in the past 12 months

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1482
  • Lead/follow: no public data

Portfolio highlights

  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Show all investments...

ARCH Venture Partners
VC Fund · Chicago, Illinois, United States · 43 investments in Life Science startups

ARCH Venture Partners provides seed / early stage venture capital for technology firms in information technology, life sciences, and physical sciences

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, China, United Kingdom

Investor stats

  • Total investments: 458
  • Round size: Series A $9.5M–$216M; Series B $14M–$230M; Series C $18M–$167M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely actively investing — fresh fund, raised $3B in 2024

Portfolio highlights

  • Happy Health — Happy Ring is the most advanced biometric platform ever - capturing clinical grade, real-world data for research and enabling real-time.
  • Synchron — The endovascular brain computer interface.
  • Parabilis Medicines — Parabilis Medicines is a biopharmaceutical company in the clinical stage that focuses on developing exceptional medications targeting challenging protein structures previously deemed undruggable. Utilizing more than ten years of exclusive data, innovative laboratory techniques, and algorithms based on AI and physics, the company has introduced anovel category of stabilized, cell-penetrating alpha-helical peptides known as Helicons™. These peptides can modulate intracellular proteins that traditional drug modalities cannot reach.
Show all investments...

Alexandria Venture Investments
VC Fund · Pasadena, California, United States · 39 investments in Life Science startups, 19 in the past 12 months

Alexandria Venture Investments is a venture capital firm that develops work in real estate technology, and healthcare sectors. The company's strategic venture capital platform is Alexandria Venture Investments. Since its inception in 1996, the company has invested in disruptive life science, agrifood tech, and technology companies that aredeveloping transformative new modalities and platforms to meaningfully improve human health.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Canada, France

Investor stats

  • Total investments: 297
  • Round size: Seed $2M–$30M; Series A $12M–$100M; Series B $25M–$150M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • Leal Therapeutics — Leal Therapeutics develops novel therapeutics for patients.
  • Vedana Therapeutics — Vedana Therapeutics is a Seattle biotechnology company developing next-generation antibody therapies for migraine prevention.
  • Khartis Therapeutics — Khartis is a drug discovery company developing oral therapies for patients with immune-mediated and chronic diseases. The company focuses on discovering and developing drug candidates intended to address chronic conditions and immune-mediated diseases.
Show all investments...

Alumni Ventures
VC Fund · Manchester, New Hampshire, United States · 36 investments in Life Science startups

Access curated startup investment opportunities and diversified venture capital exposure designed for accredited investors.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 2682
  • Round size: Seed $880k–$9.9M; Series A $3.5M–$32M; Series B $8M–$75M
  • Lead/follow: 4% lead, 96% follow
  • Last fund: Likely actively investing — fresh fund, raised $90k in 2026

Portfolio highlights

  • LOLIWARE — LOLIWARE is rewriting the story of destructive packaging. By harnessing the power of seaweed to replace plastic at scale, LOLIWARE is tapping into its potential to regenerate our ocean and decarbonize our planet.
  • Talk Local — Need a service professional? Search the Nation's #1 Service Directory. It's Free and Fast, get connected over the phone instantly with Local Plumbers, Accountants, Computer Repair Pros, Dentists, Heating & Cooling HVAC, and other service professionals!
  • HopSkipDrive — Arranging safe, dependable transportation or children ages 6+ with qualified caregivers
Show all investments...

Google Ventures
VC Fund · Mountain View, California, United States · 30 investments in Life Science startups

GV supports innovative founders moving the world forward.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 1425
  • Round size: Seed $1.2M–$16M; Series A $6M–$100M; Series B $16M–$121M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: May invest from a new fund soon — raised $100M in 2014

Portfolio highlights

  • Gusto — Gusto develops web-based payroll solution for small- and medium-sized businesses. It operates an online platform that provides payroll, benefits, human resources, and integration services for employers and employees in the United States.Gusto offers health benefits and workers’ compensation benefits that include medical insurance, commuterbenefits, and 401(k) contributions as well as workers’ compensation insurance plans, time tracking, and integration services, and access to employees for processing payroll from web-enabled devices such as smartphones and tablets. It also provides access to employees and contractors to browse their previous pay stubs, review their payroll forms, verify their personal details, and statistics about their pay, tax payments and federal forms filing services, and security and support services.Gusto serves startups, coffee shops, doctors, creative agencies, lawyers, and boutiques. Edward Kim, Joshua Reeves, and Tomer London founded ZenPayRoll in 2011 that became Gusto, with its headquarters in San Francisco in California with an additional office in Denver in Colorado.
  • Wonder — Introducing a new kind of home dining experience. Currently available in areas of New Jersey.
  • OpenEvidence — OpenEvidence uses artificial intelligence to aggregate, synthesize, and visualize clinical evidence in understandable, clinically-useful formats that can be used to make more evidenced-based decisions and improve patient outcomes.
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 29 investments in Life Science startups

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 348
  • Round size: Series A $7M–$70M; Series B $10M–$105M; Series C $12M–$100M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely actively investing — fresh fund, raised $755M in 2025

Portfolio highlights

  • Odoo — From ERP to CRM, eCommerce and CMS. Download Odoo or use it in the cloud. Grow Your Business.
  • Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
  • Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.
Show all investments...

OrbiMed
VC Fund · New York, New York, United States · 28 investments in Life Science startups

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 727
  • Round size: Series A $9.8M–$140M; Series B $24M–$148M; Series C $19M–$160M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely actively investing — fresh fund, raised $192M in 2026

Portfolio highlights

  • CoGenesys — CoGenesys is a biopharmaceutical company focused on the development of peptide- and protein-based medicines. The company develops peptide and protein-based medicines for cancer, cardiovascular, metabolic, infectious, autoimmune, and CNS diseases.
  • Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
  • Acceleron Pharma — At Merck, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Show all investments...

Bpifrance
VC Fund · Maisons-alfort, Ile-de-France, France · 28 investments in Life Science startups

Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A
  • Geography: France, United States, Switzerland

Investor stats

  • Total investments: 1645
  • Round size: Seed $757k–$6.1M; Series A $2.9M–$34M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: Likely actively investing — fresh fund, raised $27M in 2025

Portfolio highlights

  • Melvan — Melvan develops, finances, builds and operates solar and wind installations, combined, where relevant, with storage facilities.
  • AI-Stroke — Developer of an artificial intelligence-powered mobile application designed to assist in pre-CT/MRI stroke diagnostics. The company offers a platform that guides first responders and patients through relevant exercises for stroke detection, captures and analyzes video data, and leverages the world's largest proprietary stroke patientvideo dataset (20,000 videos and 6 million images), enabling patients with a diagnosis and outcomes by reducing delays in treatment for stroke, increasing the number of treatment procedures, and recuding the rehab costs.
  • MSInsight — Explore how our cutting-edge genomic analysis uncovers actionable insights into microsatellite instability (MSI), driving targeted, personalized cancer treatments.
Show all investments...

8VC
VC Fund · San Francisco, California, United States · 27 investments in Life Science startups

8VC is a technology and life sciences investment firm that partners with founders to develop transformational technologies. The firm focuses on creating long-term economic and societal value through its investments across various sectors, including healthcare and logistics.

Show more...

Investment focus

  • Industry: Software, Health Care, Artificial Intelligence
  • Stage:Series A, Seed, Series B
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 659
  • Round size: Seed $2.5M–$13M; Series A $7.7M–$55M; Series B $17M–$175M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: Likely actively investing — fresh fund, raised $45M in 2026

Portfolio highlights

  • Saronic — Providing the most advanced and capable autonomous vessels in the maritime domain.
  • Apex — Apex manufactures ESPA-class satellites, ranging from 40 to 400kg. Our first spacecraft bus platform, Aries, is built for LEO missions for earth observation, communications, and more. Configure the Aries bus to meet your specific mission profile.
  • Fieldguide — Fieldguide is a workflow automation and collaboration software platform for audit, attestation, assurance, and advisory practices and firms.
Show all investments...

Parkwalk Advisors
VC Fund · London, England, United Kingdom · 25 investments in Life Science startups

Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Philippines

Investor stats

  • Total investments: 316
  • Round size: Seed $991k–$4.9M; Series A $1.6M–$14M; Series B $2.2M–$45M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • xWatts — xWatts is an intelligent energy management software that reduces energy costs and emissions in commercial buildings.
  • K3 Metrology — K3 Metrology is a specialist metrology company commercialising laser‑based 3D coordinate measurement technology developed at the National Physical Laboratory. The company’s platform is designed to provide high‑accuracy, uncertainty‑aware dimensional data in large‑volume industrial environments, supporting inspection and assembly processes inadvanced manufacturing. Its systems integrate into production workflows where traceable measurements are required across complex geometries and large structures. The technology is applied in sectors such as aerospace, defence, and nuclear, where dimensional integrity and process control are critical.
  • MoA Technology — We harness the principles of natural selection to accelerate discovery for better, safer herbicides so farmers can continue to feed the world.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Atlas Venture
VC Fund · Cambridge, Massachusetts, United States · 25 investments in Life Science startups

Atlas Venture is an early-stage venture capital firm that creates and invests in biotech startup companies led by promising entrepreneurs focusing on life sciences innovation. Its seed-led venture creation strategy rigorously selects and focuses investment on compelling opportunities to build scalable businesses and realize value.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 453
  • Round size: Series A $3.6M–$77M; Series B $8M–$115M; Series C $6M–$95M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: Likely actively investing — fresh fund, raised $400M in 2025

Portfolio highlights

  • E Ink — E Ink Corp. is a supplier of electronic paper display (EPD) technologies. Products made with E Ink's electronic ink are designed to possess a paper-like high contrast appearance, ultra-low power consumption, and a thin, light form. E Ink's technology is tailored for many consumer and industrial applications including handheld devices,watches, clocks, and public information and promotional signs.
  • Songbird — DropCatch.com helps you secure expiring domain names.
  • Kinaset Therapeutics — Kinaset Therapeutics is a therapeutics company that focuses on the advancement of novel drugs in areas of unmet medical needs. The company was founded in 2020 and is headquartered in Medfield, Massachusetts.
Show all investments...

Gaingels
VC Fund · New York, New York, United States · 23 investments in Life Science startups

Gaingels is a venture investment syndicate in service of the LGBT+ community and its allies, investing in companies with LGBT+ founders and C-suite leaders at all stages of growth, as well as in more established companies resolved on building more inclusive teams, with a global portfolio of 130+ companies and $70M in deployed investment capital todate. The Gaingels network also actively supports its portfolio in identifying and recruiting diverse talent to their C-suite and board leadership teams and fosters a vibrant global community of industry leaders, investors, operators, and entrepreneurs who share a common goal for positive social change through business and successful investments.

Show more...

Investment focus

  • Industry: Software, Health Care, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, Mexico

Investor stats

  • Total investments: 1335
  • Round size: Seed $1M–$8.2M; Series A $5M–$35M; Series B $16M–$100M
  • Lead/follow: 1% lead, 99% follow
  • Last fund: Likely actively investing — fresh fund, raised $140k in 2026

Portfolio highlights

  • Epirus — Epirus is a high-growth technology company that develops cutting-edge directed energy systems and power management solutions to transform multiple industries.
  • BQP — At BQP, we’re developing a quantum-accelerated digital twin platform for mission-critical applications. The platform, BQPhy, is a back-end engine that integrates seamlessly into existing engineering workflows and operates on today’s infrastructure without requiring quantum hardware. BQPhy helps teams solve large-scale, complex challenges inengineering optimization, data-driven modeling (ML), and physics-based (CFD) simulations. We are bridging the gap between current high-performance computers and future quantum systems with probabilistic algorithms from quantum information science, unlocking simulation capabilities that were previously impractical or impossible. BQPhy reduces time, accuracy, and throughput inefficiencies, thereby accelerating development cycles, unlocking previously unexplored design spaces, lowering costs, and enhancing product outcomes.
  • Sharper Sense — Neuromodulation for Clear Senses
Show all investments...

Northpond Ventures
VC Fund · Bethesda, Maryland, United States · 23 investments in Life Science startups

Northpond Ventures is a science-driven venture capital firm headquartered in Bethesda, Maryland. Our mission is to build a better tomorrow. Our investments are focused on life sciences, technology, and affiliated industries.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Series A, Series B, Series C
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 151
  • Round size: Series A $13M–$65M; Series B $15M–$95M; Series C $23M–$85M
  • Lead/follow: 59% lead, 41% follow

Portfolio highlights

  • Faro AI — The AI Platform for Clinical Development
  • Culture Biosciences — Culture Biosciences provides a platform of cloud-connected bioreactors, software tools, and process development services that support upstream bioprocess development for biotech and biopharma applications. The company’s offerings include remote experiment design, monitoring, and data analysis through an integrated cloud software interface pairedwith single-use bioreactors for microbial fermentation and cell culture experimentation. Its services encompass clone and strain screening, process optimization, characterization, and bioprocess modeling to help scientific teams refine and scale their workflows. Clients access real-time data and analytics to inform decisions and collaborate across teams using the platform’s tools. Culture Biosciences’s technology is used to advance development of therapeutics, synthetic biology products, and related bioprocesses. Culture Biosciences was founded in 2016 and is headquartered in San Francisco, California.
  • EnPlusOne Biosciences — EnPlusOne Biosciences provides innovative solutions for emerging RNA therapeutics.
Show all investments...

Third Rock Ventures
VC Fund · Boston, Massachusetts, United States · 22 investments in Life Science startups

Third Rock Ventures invests in transformational life science companies that show high growth potential and are well-positioned to make a difference in the marketplace. Third Rock Ventures believes in the companies we start and makes significant initial investments, which are frequently supplemented by strategic collaborations, to help our firmsprogress in life-changing medicines, technologies, and diagnostics.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States

Investor stats

  • Total investments: 174
  • Round size: Series A $19M–$110M; Series B $11M–$190M; Series C $20M–$108M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: Likely still investing — raised $1.1B in 2022

Portfolio highlights

  • Corvia Medical — Corvia Medical is a medical device company, focuses on developing structural heart devices for the treatment of heart failure. The company develops InterAtrial Shunt Device (IASD), a transcatheter device designed to treat diastolic heart failure (DHF), also known as heart failure with preserved ejection fraction (HFpEF). It was founded in 2009and headquartered in Andover, Massachusetts.
  • NinePoint Medical — NinePoint Medical, Inc. is a transformational medical device company developing innovative, real-time, in vivo pathology devices. The company's first goal is to develop a device that enables remote pathology, or telepathology, which would facilitate immediate review of images during diagnostic procedures. This capability could potentiallyprovide physicians with immediately actionable information and eventually allow them to pursue therapeutic remedies at the time of diagnosis. This convergence of access, diagnosis and treatment during one procedure is expected to improve patient experiences and outcomes, improve the efficiency of care and provide important savings to the healthcare system. Headquartered in Cambridge, Mass., NinePoint is backed by Third Rock Ventures and Prospect Venture Partners.
  • CytomX Therapeutics — CytomX Therapeutics is a biotechnology company that focuses on developing proteolytically-activated antibodies. Their mission, alone and with the help of partners, is to provide patients with more effective and less toxic therapies for severe illnesses such as cancer and inflammatory diseases.
Show all investments...

RA Capital Management
VC Fund · Boston, Massachusetts, United States · 21 investments in Life Science startups

RA Capital Management is an investment advisor based in Boston specializing in the life-sciences and drug development sectors. The company's team has been investing since 2002 and is comprised of professionals with training in biology, chemistry, and medicine and also has industry and business development experience at the executive and boardlevels. The company invests in companies with promising technologies and products.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series C, Post-IPO Equity
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 550
  • Round size: Series B $27M–$152M; Series C $44M–$182M; Post-IPO Equity $35M–$240M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely actively investing — fresh fund, raised $120M in 2025

Portfolio highlights

  • Serapha Bio
  • Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
  • Kinaset Therapeutics — Kinaset Therapeutics is a therapeutics company that focuses on the advancement of novel drugs in areas of unmet medical needs. The company was founded in 2020 and is headquartered in Medfield, Massachusetts.
Show all investments...

Novartis Venture Fund
VC Fund · Basel, Basel-Stadt, Switzerland · 20 investments in Life Science startups

Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 230
  • Round size: Series A $5.1M–$85M; Series B $11M–$120M; Series C $9M–$75M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $200M in 2009

Portfolio highlights

  • Visiogen — Visiogen, Inc. is an ophthalmic medical device company specializing in the development of new vision alternatives for patients with cataracts, with and without presbyopia. As part of this mission, Visiogen created the Synchrony dual optic accommodating *intraocular lens (IOL)* for use in the surgical treatment of these conditions.The device isdesigned to provide patients with near, intermediate and distance vision in a seamless continuum without the need for glasses or contact lenses. To eliminate lens handling during surgery, the Synchrony dual optic IOL is provided in a pre-loaded injector. This patented technology has been approved in Europe with a CE Mark designation and is currently undergoing clinical trials in the United States.
  • Protego Biopharma — Protego Biopharma develops therapeutics based on the clear human genetic link, excellent human safety profile, proof-of-principle efficacy. The company was founded in 2011 and is headquartered in San Diego, California.
  • Rein Therapeutics — Rein Therapeutics is advancing a novel pipeline of first-in-class medicines to address unmet medical needs in orphan pulmonary and fibrosis indications.
Show all investments...

Andreessen Horowitz
VC Fund · Menlo Park, California, United States · 20 investments in Life Science startups

Andreessen Horowitz (a16z) is a venture capital firm in Silicon Valley, California, investing in bold founders, innovators, and entrepreneurs building the future through technology.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Series A, Seed, Series B
  • Geography: United States, United Kingdom, Brazil

Investor stats

  • Total investments: 2033
  • Round size: Seed $1.6M–$16M; Series A $9M–$55M; Series B $17M–$112M
  • Lead/follow: 50% lead, 50% follow
  • Last fund: Likely actively investing — fresh fund, raised $1.2B in 2026

Portfolio highlights

  • Slack — Slack is a cloud-based communication and collaboration platform for teams. It allows users to exchange messages, share files, and integrate with various business tools and services. Slack is commonly used across various industries, from tech startups to large enterprises.
  • Socket — Socket fights vulnerabilities and provides visibility, defense-in-depth, and proactive supply chain protection for JavaScript, Python, and Go dependencies.
  • Mercury — Everything you do with money. All in one place. Apply in 10 minutes for business banking that transforms how you operate.
Show all investments...

Liquid 2 Ventures
VC Fund · San Francisco, California, United States · 20 investments in Life Science startups

Liquid2 Ventures provides technology startups with seed-stage investments and is based in San Francisco, California. The firm was founded in 2015 by Joe Montana, Mike Miller, and Michael Ma.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Mexico, Canada

Investor stats

  • Total investments: 1212
  • Round size: Seed $1.1M–$9.1M; Pre-Seed $125k–$2.7M; Series A $6M–$45M
  • Lead/follow: 1% lead, 99% follow
  • Last fund: Likely actively investing — fresh fund, raised $12M in 2026

Portfolio highlights

  • Albedo — Aerial quality imagery - from space.
  • Eden — Eden unifies medical imaging operations with clinical AI: PACS, teleradiology, AI-assisted diagnosis and structured reporting, deployed across 2,600+ imaging departments.
  • Vulcan — Frontier AI for government, law, and policy | backed by @ycombinator @generalcatalyst @cubitcapital
Show all investments...

Fifty Years
VC Fund · San Francisco, California, United States · 20 investments in Life Science startups

WE BACK HEROES using technology to solve the world's biggest problems

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Germany, Canada

Investor stats

  • Total investments: 211
  • Round size: Seed $2M–$13M; Pre-Seed $572k–$3.3M; Series A $8.5M–$37M
  • Lead/follow: 18% lead, 82% follow
  • Last fund: Likely still investing — raised $90M in 2021

Portfolio highlights

  • Gridware — Using remote telemetry and edge AI, Gridware wildfire prevention technology powers a grid that is smarter and more reliable than ever before.
  • Onepot.ai — Search 2.7 billion make-on-demand analogs from onepot CORE, get a quote, and we synthesize and QC them in our US-based lab. AI-powered custom synthesis.
  • Adaption Labs — Adaptation creates AI systems that adjust to changing real-world circumstances.
Show all investments...

Oxford Science Enterprises
VC Fund · Oxford, Oxfordshire, United Kingdom · 19 investments in Life Science startups

Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking onchallenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Finland

Investor stats

  • Total investments: 202
  • Round size: Seed $1.3M–$12M; Series A $6.3M–$45M; Series B $9.1M–$168M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely still investing — raised $299M in 2022

Portfolio highlights

  • Caudal Energy — Porpoise Power develops a tidal energy system using oscillating hydrofoil technology inspired by dolphin swimming mechanics.
  • Singular Machines — Singular Machines is an engineering automation company that provides solutions to engineering issues.
  • Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Antler
VC Fund · Singapore, Central Region, Singapore · 19 investments in Life Science startups

Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Pre-Seed, Seed, Series A
  • Geography: Singapore, Australia, United Kingdom

Investor stats

  • Total investments: 2372
  • Round size: Seed $158k–$4.5M; Pre-Seed $100k–$587k; Series A $4.1M–$29M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: Likely actively investing — fresh fund, raised $7.5M in 2026

Portfolio highlights

  • Two — Buy Now, Pay Later for your business customers. Two makes it easy and safe to offer invoice as a payment method on your e-commerce site.
  • Forti Foods — The mission of Forti Foods is to enhance communities and change lives beyond the plate by fostering resilience and dignity via sustainable food innovation.
  • RubiLabs — RubiLabs Inc provides a platform for unifying, monitoring, and analyzing organizational data. RubiLabs software enables analysts and operators across risk, compliance, and security teams to collaborate and interpret large volumes of information in real time. The company’s platform is designed to help institutions make sense of complex, fragmenteddata by transforming it into a coherent operational picture for risk detection, continuous monitoring, and investigative workflows.
Show all investments...

2048 Ventures
VC Fund · New York, New York, United States · 18 investments in Life Science startups, 12 in the past 12 months

We back visionary founders who are building technologies of the future.2048 Ventures is a thesis-driven earliest stage venture capital firm. We are founders, experienced operators, nerds and dreamers obsessed with the future. We've backed over 200 startups and have the experience and conviction to lead your pre-seed or seed round.We getyou and your vision before others.We are systems thinkers, engineers, and product junkies. We think about the future non-stop and are ready to understand and back you before anyone else. When we decide to invest, we write you a check and then help you close the rest of the round. We lead rounds with high conviction, and write $500K - $2M checks.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Health Care
  • Stage:Pre-Seed, Seed, Series A
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 213
  • Round size: Seed $1.5M–$6.5M; Pre-Seed $615k–$2.5M; Series A $8M–$16M
  • Lead/follow: 68% lead, 32% follow
  • Last fund: Likely actively investing — fresh fund, raised $82M in 2026

Portfolio highlights

  • Rely — Rely is a company that focuses on converting the vast amount of unstructured data found in real estate transactions into structured.
  • GlossGenius — GlossGenius is the all-in-one booking, payments and POS solution that helps beauty and wellness professionals drive bookings and grow your business.
  • Genius AI — Building technology to help service businesses run themselves
Show all investments...

SR One
VC Fund · Cambridge, Massachusetts, United States · 18 investments in Life Science startups

SR One Capital Management is a leading trans-Atlantic biotech venture capital firm that partners with top entrepreneurs, scientists and investment partners to seek to build elite biotechnology companies. Our mission is to translate ground-breaking technologies into next generation medicines to benef

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 200
  • Round size: Series A $6M–$100M; Series B $15M–$114M; Series C $22M–$175M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: Likely actively investing — fresh fund, raised $237M in 2025

Portfolio highlights

  • CalciMedica — CalciMedica was founded in December 2006 by Gonul Velicelebi, Ph.D., Kenneth Stauderman, Ph.D. and Jack Roos, Ph.D., all previously with TorreyPines Therapeutics, where they discovered the role of STIM1 in the Icrac pathway in 2003. Other co-founders, all from the CBR Institute, include Anjana Rao, Ph.D., Patrick Hogan, Ph.D. and Stefan Feske, M.D,who identified Orai1 as the CRAC channel subunit in 2006.
  • Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
  • CHARM Therapeutics — CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.
Show all investments...

M Ventures
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 17 investments in Life Science startups

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Switzerland

Investor stats

  • Total investments: 186
  • Round size: Seed $2.4M–$24M; Series A $5.8M–$50M; Series B $15M–$100M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • iOnctura — Our mission is to develop high impact, low disruption therapies that extend healthspan. We do this by disrupting the dynamic interplay at the heart of the
  • Quintessent — Quintessent is developing optical connectivity solutions to scale computing and Artificial Intelligence (A.I.).
  • Remepy — Redefining combination therapy by fusing traditional pharmaceuticals with clinically validated app-delivered protocols in a single, regulated prescription.
Show all investments...

Lux Capital
VC Fund · New York, New York, United States · 17 investments in Life Science startups

Lux Capital manages over $5 billion in assets focused on founding, seed, early-stage, and growth investments at the intersection of technology and the sciences. Lux takes an active role in helping entrepreneurs build successful businesses in high-growth sectors. Its investment team has built over 20 companies from scratch. Lux's investmentstrategy ensures portfolio companies are better connected, have a deeper insight, and command industry leadership faster than their competitors.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Series A, Seed, Series B
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 675
  • Round size: Seed $1.8M–$25M; Series A $7M–$90M; Series B $13M–$150M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: Likely actively investing — fresh fund, raised $10M in 2026

Portfolio highlights

  • Adimab — Premier Human Antibody Discovery and Optimization
  • Toonimo — Toonimo humanize the web user experience with an engaging and personalized step-by-step interactive walkthrough
  • Cajal Neuroscience — Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.
Show all investments...

Khosla Ventures
VC Fund · Menlo Park, California, United States · 17 investments in Life Science startups

Khosla Ventures is a venture capital firm that invests in early- to late-stage companies across sectors like AI, healthcare, sustainability, and consumer technology. It manages multiple funds, focusing on startups with innovative technologies or business models. The firm primarily targets sectors like AI, climate tech, digital health, and medtech,offering strategic support to help build long-lasting companies.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1407
  • Round size: Seed $2M–$23M; Series A $5.5M–$47M; Series B $11M–$100M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely actively investing — fresh fund, raised $31M in 2026

Portfolio highlights

  • Phia — Build your closet seamlessly, and find the best prices instantly.
  • NavigateAI — An AI copilot for every person in the field. NavigateAI upskills and coaches your team, runs real-time quality control, manages the project in the background, and provides expert knowledge, instantly.
  • Blue River Technology — Blue River Technology is a pioneer in the use of computer vision and robotics for agriculture. Founded in 2011 by two Stanford University Alumni, Blue River Technology is bringing crop protection into the digital era with See & Spray machines that precisely observe and treat each plant in a field. By applying herbicides only to weeds thesemachines dramatically reduce the amount of chemicals used, enable farmers the freedom to choose any herbicide that meets their needs, and improve grower economics. Currently, farmers are limited to equipment that applies fertilizer and chemicals inefficiently across an entire field. In contrast, Blue River have developed tractor-towed robots that are able to sense each individual plant and precisely apply the right amount of inputs – all in real time, at tractor speeds.
Show all investments...

UK Innovation & Science Seed Fund
VC Fund · Harwell, Oxfordshire, United Kingdom · 17 investments in Life Science startups

UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 147
  • Round size: Seed $482k–$5.9M; Series A $2.9M–$14M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • Zentraxa — NATURE ENGINEERED FOR PURPOSE Through millions of years of evolution, nature has found solutions to the most difficult problems. Inspired by the diversity of nature, we precision engineer bespoke biomaterials to meet the toughest challenges across
  • Singular Machines — Singular Machines is an engineering automation company that provides solutions to engineering issues.
  • Halo X Ray Technologies — HALO X-ray Technologies - next generation X-ray diffraction technology for the aviation security, medical and process control markets.
Show all investments...

Felicis
VC Fund · Menlo Park, California, United States · 16 investments in Life Science startups

Backing founders building iconic companies that transcend boundaries

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Series A, Seed, Series B
  • Geography: United States, Canada, Germany

Investor stats

  • Total investments: 672
  • Round size: Seed $1.5M–$14M; Series A $4.4M–$42M; Series B $10M–$75M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: Likely actively investing — fresh fund, raised $900M in 2025

Portfolio highlights

  • Midi Health — Expert care for women 40+. Made for midlife. Delivered by experienced clinicians. Covered by insurance. Book a visit today.
  • Petasense — Founded with a vision of making industrial machines smarter, Petasense is an Industrial IoT startup based in Silicon Valley. The company offers an end-to-end solution – comprised of a patent-pending wireless vibration sensor, cloud software and machine learning analytics – that helps with asset reliability and predictive maintenance. Customersare able to monitor, assess and predict the health of their critical machines in real-time. This helps them reduce unplanned downtime and lower repair costs. Petasense's clients include industry leaders like JLL, C&W Services, Silicon Valley Power and Stanford University. Petasense is backed by True Ventures, Felicis Ventures and top angel investors. The company is founded by serial entrepreneurs, Abhinav Khushraj and Arun Santhebennur, who have 25 years of combined experience in building enterprise companies, with degrees from MIT and IIT.To learn more about Petasense, visit www.petasense.com.
  • General Proximity — The next generation of induced-proximity medicines. We're here to put a dent in the universe.
Show all investments...

Flagship Pioneering
VC Fund · Cambridge, Massachusetts, United States · 16 investments in Life Science startups

We create breakthroughs in human health and sustainability and build bioplatform companies . Companies founded

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series C, Series A
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 244
  • Round size: Series A $6.5M–$88M; Series B $11M–$230M; Series C $12M–$123M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: Likely still investing — raised $2.6B in 2024

Portfolio highlights

  • ZoomInfo — ZoomInfo provides access to more direct dials and email addresses than any other B2B contact provider. Verified professional and business profiles come fully loaded with detailed information about prospects, including web mentions, employment history, and direct access to colleagues, people can engage ideal buyer personas and accounts in a moremeaningful way. ZoomInfo uses its diverse portfolio of proprietary technology, a community of 300,000+ users, and third-party integrations to collect, organize, validate, and publish a comprehensive directory of business data in the marketplace.ZoomInfo's mission is to provide every company with a 360-degree view of their ideal customer, empowering each phase of their go-to-market strategy, and driving their ability to hit their number. ZoomInfo was founded in 2000 and is headquartered in Waltham, Massachusetts.
  • Foghorn Therapeutics — Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express, and when, where, and in what order.By manipulating this system with our unique Gene Traffic ControlTM platform, Foghorn will change how genes turn “on” and “off.” Unlike approaches that edit genes, this novel way of thinking will alter whatour DNA has in store for us—and rewrite destiny for millions of people living with disease.With Gene Traffic ControlTM Foghorn is pioneering a new, major class of drug targets to develop unprecedented therapies for cancer and other serious diseases. We have already validated multiple targets, are in the process of developing drug candidates in multiple types of cancer and are beginning to explore other diseases.
  • Serif Bio­med­i­cines — Serif Biomedicines is pioneering Modified DNA as a new type of biotechnology. Serif combines nucleic acid chemistry, synthetic biology, delivery technology, and artificial intelligence to develop programmable, scalable, long-lasting, and redosable DNA therapies.
Show all investments...

DCVC
VC Fund · San Francisco, California, United States · 16 investments in Life Science startups

We are deep tech venture capital.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Machine Learning
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 472
  • Round size: Seed $1.2M–$10M; Series A $6M–$45M; Series B $15M–$130M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: Likely actively investing — fresh fund, raised $5M in 2026

Portfolio highlights

  • CH4 Global — CH4 Global is an aquaculture solutions provider dedicated to urgently impacting climate change at scale. Lead by a world-class team of senior business builders, scientists and entrepreneurs, the company is initially leveraging proven science and technology for growing seaweed into innovative new livestock supplement that reduces methane produced bycows by up to 90%. Among early investors are a select group of prominent family offices and private investors. CH4 Global have also received non-dilutive capital support from government organizations from around the world. CH4 Global is a Delaware corporation based in Henderson, NV.
  • Regent — We build all-electric, passenger-carrying, wing-in-ground-effect vehicles to service coastal routes with technology available today.
  • Callosum — Callosum - Co-evolving chips & intelligence
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Versant Ventures
VC Fund · Menlo Park, California, United States · 16 investments in Life Science startups

Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Switzerland, Canada

Investor stats

  • Total investments: 317
  • Round size: Series A $5M–$78M; Series B $11M–$107M; Series C $12M–$108M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: Likely still investing — raised $5M in 2024

Portfolio highlights

  • Inari Medical — Inari Medical is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. They are focused on treating venous thromboembolism and improving the quality of life of patients suffering from this disease by safely and effectively removing blood clots. It hasdeveloped two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The ClotTriever system is 510(k)-cleared by the FDA for thrombectomy in the peripheral vessels and is used to treat patients suffering from deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA for the treatment of pulmonary embolism.The company was founded in 2011 and is headquartered in Irvine, California.
  • Gate Bioscience — Gate Bioscience is developing Molecular Gates, a new frontier in protein elimination. Molecular Gates are small molecule drugs that selectively eliminate harmful extracellular proteins at their origin, inside cells, and prevent them from emerging to cause disease.
  • Dayra Therapeutics — Dayra Therapeutics manufactures peptide based medicines.
Show all investments...

KdT Ventures
VC Fund · Austin, Texas, United States · 15 investments in Life Science startups

KdT Ventures is the standard for early-stage frontier science investing.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United States, India, Canada

Investor stats

  • Total investments: 96
  • Round size: Seed $2.6M–$13M; Series A $9M–$70M; Series B $25M–$175M
  • Lead/follow: 9% lead, 91% follow
  • Last fund: Likely actively investing — fresh fund, raised $4.9M in 2026

Portfolio highlights

  • Zag Bio — Zag Bio is harnessing the immune system in a whole new way by targeting the thymus to change treatment possibilities for millions of patients with autoimmune diseases.
  • Skeletalis — Skeletalis is a biotechnology startup focused on developing next-generation precision medicines for musculoskeletal diseases, primarily osteoporosis.
  • Tacit Therapeutics — New broadly-applicable and non-immunogenic RNA gene therapy that can treat thousands of devastating illnesses.
Show all investments...

Omega Funds
VC Fund · Boston, Massachusetts, United States · 15 investments in Life Science startups

We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 169
  • Round size: Series A $16M–$200M; Series B $38M–$165M; Series C $14M–$208M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: Likely still investing — raised $470M in 2023

Portfolio highlights

  • Ousia Pharma — Ousia Pharma is paving the way for novel therapeutic strategies using peptide-drug-conjugates
  • Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
  • Protego Biopharma — Protego Biopharma develops therapeutics based on the clear human genetic link, excellent human safety profile, proof-of-principle efficacy. The company was founded in 2011 and is headquartered in San Diego, California.
Show all investments...

General Catalyst
VC Fund · Cambridge, Massachusetts, United States · 15 investments in Life Science startups

Investing in powerful, positive change that endures

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Series A, Seed, Series B
  • Geography: United States, United Kingdom, India

Investor stats

  • Total investments: 2219
  • Round size: Seed $1.8M–$18M; Series A $6.7M–$75M; Series B $14M–$125M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: Likely actively investing — fund raised in 2026

Portfolio highlights

  • Datalogix — Datalogix® is the industry-recognized leader at connecting digital media and offline purchasing data. We help more than half of the top 100 consumer marketers increase the effectiveness and measurability of their advertising. DLX Platform®, encompasses over $1 trillion in consumer spending and powers campaigns for more than 75% of online mediacompanies. DLX ROI® is rapidly becoming the industry standard for measuring offline sales lift for digital media. Datalogix also offers predictive analytics for Direct Mail, and integrated media solutions via the DLX Net. Our expertise spans the major consumer segments, including Retail, CPG, Automotive, Telecom, Travel and Financial Services. We are based in Colorado, with offices in New York City, San Francisco, Boston, Chicago, Detroit, and London.
  • Legora — By streamlining and simplifying legal workflows, we empower elite law firms and legal professionals to work more efficiently and effectively. Enabling them to focus on higher-value tasks and deliver exceptional results for their clients.
  • Empathy — Coping with the loss of a loved one is not easy. Download the Empathy App for guidance on what to expect following a loss and the tools to get you through each step.
Show all investments...

Future Planet Capital
VC Fund · London, England, United Kingdom · 15 investments in Life Science startups

Brilliant Ideas. Brilliant People. Brilliant Minds.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note
  • Geography: United Kingdom, United States, Singapore

Investor stats

  • Total investments: 264
  • Round size: Seed $670k–$5.1M
  • Lead/follow: 5% lead, 95% follow
  • Last fund: Likely still investing — raised $23M in 2022

Portfolio highlights

  • Unloq AI — Unloq is a Decision Intelligence Platform that turns your company data and live market signals into governed strategic recommendations. Approved, tracked, measured.
  • Nourished — At Nourished we create innovative. personalised nutrition stacks that are truly unique to you. Vegan, waste-free and always made to order.
  • K3 Metrology — K3 Metrology is a specialist metrology company commercialising laser‑based 3D coordinate measurement technology developed at the National Physical Laboratory. The company’s platform is designed to provide high‑accuracy, uncertainty‑aware dimensional data in large‑volume industrial environments, supporting inspection and assembly processes inadvanced manufacturing. Its systems integrate into production workflows where traceable measurements are required across complex geometries and large structures. The technology is applied in sectors such as aerospace, defence, and nuclear, where dimensional integrity and process control are critical.
Show all investments...

Novo Holdings
VC Fund · Hellerup, Hovedstaden, Denmark · 15 investments in Life Science startups

Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Denmark, United Kingdom

Investor stats

  • Total investments: 395
  • Round size: Series A $9.5M–$133M; Series B $15M–$135M; Series C $30M–$118M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — raised $165M in 2018

Portfolio highlights

  • Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
  • PTC Therapeutics — Translating Science. Transforming Lives.
  • SCHOTT Poonawalla — SCHOTT Poonawalla is a manufacturer of pharmaceutical containers, made of neutral glass tubing. The company provides parenteral packaging systems crafted from tubular glass, serving the pharmaceutical industry with a broad range of products including vials, pre-fillable syringes, ampoules, and cartridges.
Show all investments...

Catalio Capital Management
VC Fund · Baltimore, Maryland, United States · 15 investments in Life Science startups

Catalio Capital Management was created by George Petrocheilos and Dr. Jacob Vogelstein to invest in breakthrough biomedical technology companies created or referred by Catalio Capital Management, an elite group of world-renowned, serial scientist-entrepreneurs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Series A, Series B
  • Geography: United States, Switzerland, Israel

Investor stats

  • Total investments: 144
  • Round size: Series A $9.7M–$150M; Series B $26M–$130M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely actively investing — fresh fund, raised $16M in 2026

Portfolio highlights

  • OSPRI — OSPRI is updating the infectious illness testing plan. Established by the combination of Community Direct DX, Scienetix, and the R&D section of Advanta Genetics, OSPRI is among the first molecular testing platforms in the world to be entirely vertically integrated.
  • Ratio Therapeutics — Ratio is a privately held discovery-stage biotechnology company that utilizes a suite of technologies licensed from Cornell University to develop best-in-class targeted radiotherapeutics for the treatment of metastatic cancers.
  • Parabilis Medicines — Parabilis Medicines is a biopharmaceutical company in the clinical stage that focuses on developing exceptional medications targeting challenging protein structures previously deemed undruggable. Utilizing more than ten years of exclusive data, innovative laboratory techniques, and algorithms based on AI and physics, the company has introduced anovel category of stabilized, cell-penetrating alpha-helical peptides known as Helicons™. These peptides can modulate intracellular proteins that traditional drug modalities cannot reach.
Show all investments...

F-Prime
VC Fund · Cambridge, Massachusetts, United States · 14 investments in Life Science startups

F-Prime Capital is a global venture capital firm investing in healthcare and technology, with a heritage that spans four decades.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, United Kingdom, China

Investor stats

  • Total investments: 513
  • Round size: Series A $9.2M–$87M; Series B $15M–$112M; Series C $20M–$150M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Innovent Biologics — Innovent Biologics, Inc. is a privately held biopharmaceutical company that is dedicated to the development and manufacturing of monoclonal antibodies to be marketed in China and elsewhere around the world. Innovent is funded by the venture arm of Fidelity, which is a major investment firm in the US, Lilly Ventures, and Suzhou bioBay. Theregistered capital is 30Million US Dollars. The founders and senior management team of Innovent have over 70 years of combined work experience in the discovery, development and manufacture of biologics in the US, Europe and worldwide and were involved in the launch of such products as Bexxar, Conbercept, Natrecor, Oncorine, Recombivax HB, and others.
  • Mersana Therapeutics — Discover how Day One is disrupting the status quo of traditional drug development to bring new medicines to children and adults with cancer.
  • PlasmaGen Biosciences — PlasmaGen BioSciences is an Indian Bio-pharmaceutical organization specializing exclusively in Plasma Protein Therapy.Headquartered in Bangalore- India, PlasmaGen has been making every effort in the domain of Plasma product Industry and has become an Imperative one stop destination for the medical fraternity for most of the plasma products need.They have a basket of plasma products and the widest range of immunoglobulins in India catering to the requisites of various realms viz. Haematology, Oncology, Immunology, Paediatrics, Rheumatology, Dermatology and Neurology.
Show all investments...

Syncona Partners LLP
VC Fund · London, England, United Kingdom · 14 investments in Life Science startups

Syncona is a FTSE250 company focused on founding, building and funding healthcare companies to deliver transformational treatments to patients in areas of high unmet need.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: United Kingdom, United States, Switzerland

Investor stats

  • Total investments: 75
  • Round size: Seed $1.9M–$17M; Series A $13M–$87M; Series B $29M–$156M
  • Lead/follow: 59% lead, 41% follow

Portfolio highlights

  • Apini Therapeutics — Apini is a creating novel small chemical two most prevalent types of inflammatory bowel disease.
  • Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
  • Re-Aim Therapeutics — Re‑Aim Therapeutics is a UK‑based biotech start‑up developing functional cures for T cell–mediated autoimmune diseases by selectively depleting pathogenic T‑cell subsets. Its lead asset, REA‑001, is a monoclonal antibody designed to potently and precisely eliminate disease‑causing type‑17 T cells, aiming to reset the immune system and achievedurable, treatment‑free remission in multiple autoimmune conditions.
Show all investments...

Bossa Invest
VC Fund · São Paulo, Sao Paulo, Brazil · 14 investments in Life Science startups, 33 in the past 12 months

Aprenda a Investir em Startups

Show more...

Investment focus

  • Industry: Software, Information Technology, Financial Services
  • Stage:Seed, Pre-Seed, Venture - Series Unknown
  • Geography: United States, Brazil, Mexico

Investor stats

  • Total investments: 2047
  • Round size: Seed $178k–$5.8M; Pre-Seed $50k–$2M; Venture - Series Unknown $632k–$36M
  • Lead/follow: 3% lead, 97% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • FFID — FFID develops AI chatbot platform automating customer communication, lead generation, and marketing workflows.
  • Sandwiche — Sandwiche creates customizable link in bio pages enabling social media monetization and affiliate marketing management.
  • Ambar Technologies — Ambar is a construction tech company that is focused on addressing the Affordable Housing Challenge. Ambar is a leading construction technology company in Latin America. Tech Company focused on addressing the Affordable Housing Challenge. Ambar integrates the Housing Journey into 4 steps, Design, Supply, Assembly, and Living.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Right Side Capital Management
VC Fund · San Francisco, California, United States · 14 investments in Life Science startups

Systematic Pre-Seed Startup Capital

Show more...

Investment focus

  • Industry: Software, SaaS, Health Care
  • Stage:Seed, Pre-Seed, Convertible Note
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 1881
  • Round size: Seed $50k–$2M; Pre-Seed $50k–$450k; Convertible Note $50k–$400k
  • Lead/follow: 3% lead, 97% follow
  • Last fund: Likely actively investing — fresh fund, raised $55M in 2025

Portfolio highlights

  • tbh — tbh is a developer of a mobile application designed to provide anonymous feedback to friends. The company's mobile application facilitates asking or answering questions, open text fields and invite abuse when combined with anonymity, enabling users to say things without repercussions and feel better about themselves from the positive feedbackon social networks.
  • Vidrovr — Vidrovr develops multimodal computer vision and machine learning systems to index, tag, and understand video. It processes videos with specific domain constraints, such as in sports, government, and media verticals. Its technology enables its users to search an indexed video corpus and retrieve content inside videos and link it to other media likephotos and text.The company Integrates social media to enable direct interactions between multimedia content. Vidrovr was founded in 2016 and is headquartered in New York.
  • Experio AI — Turn contracts, proposals, and expertise into instant searchable intelligence. Win more, ramp faster, never lose knowledge. Enterprise AI for services.
Show all investments...

Foresite Capital
VC Fund · San Francisco, California, United States · 14 investments in Life Science startups

We are a multi-stage investment firm, investing in companies that leverage biology and big data to transform healthcare.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series C, Series A
  • Geography: United States, United Kingdom, China

Investor stats

  • Total investments: 218
  • Round size: Series A $16M–$165M; Series B $25M–$140M; Series C $38M–$270M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: Likely still investing — raised $900M in 2024

Portfolio highlights

  • Parabilis Medicines — Parabilis Medicines is a biopharmaceutical company in the clinical stage that focuses on developing exceptional medications targeting challenging protein structures previously deemed undruggable. Utilizing more than ten years of exclusive data, innovative laboratory techniques, and algorithms based on AI and physics, the company has introduced anovel category of stabilized, cell-penetrating alpha-helical peptides known as Helicons™. These peptides can modulate intracellular proteins that traditional drug modalities cannot reach.
  • Khartis Therapeutics — Khartis is a drug discovery company developing oral therapies for patients with immune-mediated and chronic diseases. The company focuses on discovering and developing drug candidates intended to address chronic conditions and immune-mediated diseases.
  • Aeovian Pharmaceuticals — Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.
Show all investments...

Apple Tree Partners
VC Fund · New York, New York, United States · 14 investments in Life Science startups

ATP, a global leader in life sciences venture capital, is developing the next generation of transformative biotechnology companies. ATP creates science-based companies starting with assets at various stages: from working with scientists on pre-IP ideas, to spinouts from existing company pipelines. The firm provides flexible capital, strategicinsight, and operational resources to build sustainable, research-driven enterprises. ATP invests in its portfolio companies from seed stage through IPO and beyond and supports their management teams in strategic transactions and synergistic business combinations.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 98
  • Round size: Seed $3.5M–$8M; Series A $10M–$75M; Series B $29M–$100M
  • Lead/follow: 63% lead, 37% follow
  • Last fund: May invest from a new fund soon — raised $1B in 2020

Portfolio highlights

  • Ascidian Therapeutics — Ascidian Therapeutics is a biotechnology company intended for medical use in medical and clinical gene therapy.
  • Red Queen Therapeutics — Staying ahead of viral threats with new innovations in antiviral therapy
  • Deep Apple Therapeutics — Deep Apple Therapeutics is discovering new small-molecule therapeutics with unprecedented speed and exceptional acumen.
Show all investments...

Alix Ventures
VC Fund · San Francisco, California, United States · 14 investments in Life Science startups

Supporting early stage Life Science startups driving patient impact. Born from our collective experience as founders, we set out to build the fund we wanted to raise from....

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Life Science
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States

Investor stats

  • Total investments: 24
  • Round size: Seed $2M–$12M; Pre-Seed $2.7M–$2.7M; Series A $12M–$70M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • iOrganBio — The Right Cells. Consistently. At Scale.
  • Galatea Bio — Galatea Bio, a US-based biotechnology company was founder by Carlos Bustamante, Nicholas Katsanis and Alexander Ioannidis. Our mission is to drive groundbreaking discoveries in healthcare by pairing genetic diversity with cutting-edge data analytics. Our passion is fueled by a focus on populations historically underrepresented in genetics research.We achieve this by leveraging our world-class clinical network and biobank, cutting-edge algorithms, and innovative analyses to discover and validate new tests, treatments, and cures that will improve the lives of all.
  • Italic Health — Italic Health, Inc. is a healthcare technology company building a unified platform for managing patient data, medical billing, and insurance workflows. Its software integrates health records, appointment scheduling, and AI-driven analytics to improve care coordination, financial processes, and patient engagement.
Show all investments...

Civilization Ventures
VC Fund · San Francisco, California, United States · 13 investments in Life Science startups

DIGITAL HEALTH / AI DIGITAL HEALTH / AI GENE / CELL THERAPIES NASDAQ: RCKT GENE / CELL THERAPIES NASDAQ: RCKT GENOMICS / DIAGNOSTICS GENOMICS / DIAGNOSTICS SYNTHETIC

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Brazil

Investor stats

  • Total investments: 76
  • Round size: Seed $1.8M–$16M; Series A $8.1M–$30M; Series B $24M–$144M
  • Lead/follow: 3% lead, 97% follow
  • Last fund: May invest from a new fund soon — raised $35M in 2020

Portfolio highlights

  • OxCan — Enabling curative cancer treatment through early detection
  • 10x Science — AI-native software to unlock drug development.
  • Rinascera Therapeutics — Rinascera Therapeutics develops transformative therapies for rare genetic skin diseases, including RIN-001 for Gorlin Syndrome and RIN-002 for Dystrophic Epidermolysis Bullosa (DEB).
Show all investments...

Pear VC
VC Fund · Palo Alto, California, United States · 13 investments in Life Science startups, 60 in the past 12 months

Pear VC partners with entrepreneurs from day zero to build category-defining companies.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, Brazil, Colombia

Investor stats

  • Total investments: 505
  • Round size: Seed $1.8M–$9M; Pre-Seed $250k–$3.5M; Series A $8.5M–$40M
  • Lead/follow: 19% lead, 81% follow
  • Last fund: Likely still investing — raised $3.4M in 2024

Portfolio highlights

  • Vals.ai — Private, domain-specific benchmarks in legal, tax, and finance.
  • Infinimmune — Derived from human biology, engineered for human health. Infinimmune systematically surfaces and engineers the rare antibodies evolution has already proven in people and advances them into the clinic.
  • Maximum — Maximum is a boutique agency that likes to remain small and agile. There are sixty of us, all specialists, and our advanced digital solutions are 100% generated in-house. We have a knowledgeable and sophisticated research presence, especially in the digital arena and with regard to social recruitment. This means we can make things happen for youthat other agencies can't. Giving your organization the edge takes serious research, heavyweight strategy, considered creativity and intelligent use of the digital space. This is why we've developed the Social Recruitment Monitor™ for you, the definitive index on the use of social media for recruitment purposes.
Show all investments...

Cormorant Asset Management
VC Fund · Boston, Massachusetts, United States · 13 investments in Life Science startups

Cormorant Asset Management is an employee-owned hedge fund sponsor that provides its services to pooled investment vehicles. The firm also focuses on both public and private market innovative companies in the biotechnology and life sciences marketplace.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series C, Series A
  • Geography: United States, China, Switzerland

Investor stats

  • Total investments: 245
  • Round size: Series A $16M–$102M; Series B $27M–$150M; Series C $30M–$146M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: Likely actively investing — fresh fund, raised $75M in 2025

Portfolio highlights

  • Epicrispr Biotechnologies — The Gene Expression Modulation System (GEMS) technology from Epic-Bio combines a DNA-binding protein, a tailored guide RNA, and any of a wide range of modulator proteins to generate a powerful new type of genetic medicine. GEMS medicines have the ability to precisely modify gene expression both in and out of the body. They are mutation-independent,which means that a single GEMS design can address the majority or all genetic subtypes of a disease.
  • Processa Pharmaceuticals — Founded in Oct '17 with a mission to develop products that can improve the survival and/or quality of life for patients who have a high unmet medical need.
  • Parabilis Medicines — Parabilis Medicines is a biopharmaceutical company in the clinical stage that focuses on developing exceptional medications targeting challenging protein structures previously deemed undruggable. Utilizing more than ten years of exclusive data, innovative laboratory techniques, and algorithms based on AI and physics, the company has introduced anovel category of stabilized, cell-penetrating alpha-helical peptides known as Helicons™. These peptides can modulate intracellular proteins that traditional drug modalities cannot reach.
Show all investments...

Jonathan Milner
Angel · Cambridge, Massachusetts, United States · 13 investments in Life Science startups

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Spain

Investor stats

  • Total investments: 63
  • Round size: Seed $537k–$25M; Series A $4.5M–$50M; Series B $1.6M–$56M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 230+ centers worldwide.
  • Nuclera — Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers. Nuclera's eProtein DiscoveryTM system allows scientists to rapidly produce and test proteins for drug discovery.
  • 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
Show all investments...

Forbion Capital Partners
VC Fund · Naarden, Noord-Holland, The Netherlands · 13 investments in Life Science startups

Impacting the future of medicine.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, United Kingdom, The Netherlands

Investor stats

  • Total investments: 208
  • Round size: Series A $19M–$180M; Series B $16M–$155M; Series C $19M–$120M
  • Lead/follow: 52% lead, 48% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • Azafaros — Azafaros aims at developing therapeutic agents for the treatment of rare metabolic disorders such as lysosomal storage disorders through oral administration of azasugar compounds. These novel, very promising agents were discovered by Professor Hans Aerts at Leiden University and Amsterdam UMC and are exclusively licensed to Azafaros.
  • Inflazome — Situs gacor premium Megawin188 paling banyak di minati oleh semua kalangan karena pecah selayar tanpa henti dan memiliki tampilan yang sangat memanjakan mata.
  • Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Show all investments...

Village Global
VC Fund · San Francisco, California, United States · 13 investments in Life Science startups, 21 in the past 12 months

Early stage venture capital backed by some of the world's best entrepreneurs.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Financial Services
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, India

Investor stats

  • Total investments: 514
  • Round size: Seed $1.5M–$10M; Pre-Seed $250k–$3.5M; Series A $7M–$22M
  • Lead/follow: 20% lead, 80% follow
  • Last fund: May invest from a new fund soon — raised $125M in 2021

Portfolio highlights

  • microagi — Accelerating embodied AGI
  • Legato Audio — Legato Hearing develops stylish glasses with built-in hearing technology, offering a discreet alternative to traditional hearing aids.
  • Cast Insights — Cast Insights is an AI-powered platform that turns global spoken content—TV, radio, podcasts, livestreams—into structured, searchable real-time intelligence for investors, policy teams, strategists, and newsrooms.
Show all investments...

Life Science Investor funding at a glance

Stats across 7.6k deals from 7.4k investors.

7.4k
investors
in Life Science startups
7.6k
deals
in Life Science startups
$4.5M
median round
in Life Science startups
39%
lead investors
lead at least one round
20%
Seed
most common funding stage
89/11
VC / Angel
share of investor count

Access all 7362 investors in Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science Investors investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 7362 investors investing in Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists